GliPR1 knockdown by RNA interference exerts anti‐glioma effects in vitro and in vivo

Scheuring, U. J., Ritter, S., Martin, D., Schackert, G., Temme, A. & Tietze, S., May 2021, In: Journal of neuro-oncology. 153, 1, p. 23-32 10 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Targeting integrin α2 as potential strategy for radiochemosensitization of glioblastoma

Korovina, I., Vehlow, A., Temme, A. & Cordes, N., 6 Apr 2023, In: Neuro-oncology. 25, 4, p. 648-661 14 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Efficient transduction and long-term retroviral expression of the melanoma-associated tumor antigen tyrosinase in CD34⁺ cord blood-derived dendritic cells

Temme, A., Morgenroth, A., Schmitz, M., Weigle, B., Rohayem, J., Lindemann, D., Füssel, M., & 2 othersEhninger, G. & Rieber, E. P., Nov 2002, In: Gene therapy. 9, 22, p. 1551-1560 10 p.

Research output: Contribution to journal › Review article › Contributed › peer-review

AMPA receptor antagonist CFM-2 decreases survivin expression in cancer cells

Ruiz, D. S., Luksch, H., Sifringer, M., Temme, A., Staufner, C., Rzeski, W., Marzahn, J., & 3 othersGrabarska, A., Ikonomidou, C. & Stepulak, A., 2018, In: Anti-cancer agents in medicinal chemistry. 18, 4, p. 591-596 6 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

A new approach for clinical translation of infrared spectroscopy: exploitation of the signature of glioblastoma for general brain tumor recognition

Steiner, G., Galli, R., Preusse, G., Michen, S., Meinhardt, M., Temme, A., Sobottka, S. B., & 5 othersJuratli, T. A., Koch, E., Schackert, G., Kirsch, M. & Uckermann, O., 2022, In: Journal of neuro-oncology. 161, 1, p. 57–66 10 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Arginine Deprivation Therapy: Putative Strategy to Eradicate Glioblastoma Cells by Radiosensitization

Hinrichs, C. N., Ingargiola, M., Käubler, T., Löck, S., Temme, A., Köhn-Luque, A., Deutsch, A., & 3 othersVovk, O., Stasyk, O. & Kunz-Schughart, L. A., Feb 2018, In: Molecular Cancer Therapeutics. 17, 2, p. 393-406 14 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma

Meneceur, S., Linge, A., Meinhardt, M., Hering, S., Löck, S., Bütof, R., Krex, D., & 5 othersSchackert, G., Temme, A., Baumann, M., Krause, M. & von Neubeck, C., Apr 2020, In: Cancers. 12, 4, 871.

Research output: Contribution to journal › Research article › Contributed › peer-review

Artificial feeder cells expressing ligands for killer cell immunoglobulin-like receptors and CD94/NKG2A for expansion of functional primary natural killer cells with tolerance to self

Michen, S., Frosch, J., Füssel, M., Schackert, G., Momburg, F. & Temme, A., Jul 2020, In: Cytotherapy. 22, 7, p. 354-368 15 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Bivalent Peptide- A nd Chelator-Containing Bioconjugates as Toolbox Components for Personalized Nanomedicine

Daeg, J., Xu, X., Zhao, L., Boye, S., Janke, A., Temme, A., Zhao, J., & 4 othersLederer, A., Voit, B., Shi, X. & Appelhans, D., 13 Jan 2020, In: Biomacromolecules. 21, 1, p. 199-213 15 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Bidirectional Crosstalk Between Cancer Stem Cells and Immune Cell Subsets

Müller, L., Tunger, A., Plesca, I., Wehner, R., Temme, A., Westphal, D., Meier, F., & 2 othersBachmann, M. & Schmitz, M., 5 Feb 2020, In: Frontiers in immunology. 11, 140.

Research output: Contribution to journal › Review article › Contributed › peer-review